Administration of granulocyte colony-stimulating factor (G-CSF) to an unresponsive endometrium in an IVF cycle

Phase 3

Recruiting

• Conditions: unresponsive endometrium; Reproductive Health and Childbirth - Fertility including in vitro fertilisation

• Registration Number: ACTRN12611000907943
• Lead Sponsor: Fertility Specialists of Western Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-08-24
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

thin endometrium unresposive to oral and topical oestrogen therapy prior to embryo replacement

Exclusion Criteria

women with a responsive endometrium as part of their IVF cycle

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
improvement in endometrial thickness as assessed by transvaginal ultrasonography.[5 days];livebirth rate[9 months]

Secondary Outcome Measures

Name	Time	Method
Adverse events; such as pelvic pain, vaginal bleeeding and allergic reactions as reported by the patient and healthcare professionals.[Within 24 hours of intervention];miscarriage[20 weeks of pregnancy]